|
1.
|
American Cancer Society: Colorectal Cancer
Facts & Figures 2011–2013. American Cancer Society Inc.;
Atlanta, GA: 2011
|
|
2.
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
|
|
3.
|
Conteduca V, Sansonno D, Ingravallo G,
Marangi S, Russi S, Lauletta G and Dammacco F: Barrett’s esophagus
and esophageal cancer: an overview. Int J Oncol. 41:414–424.
2012.
|
|
4.
|
Conteduca V, Sansonno D, Lauletta G, Russi
S, Ingravallo G and Dammacco F: H. pylori infection and
gastric cancer: state of the art (Review). Int J Oncol. 42:5–18.
2013.
|
|
5.
|
NCCN Clinical Practice Guidelines in
Oncology. Colorectal Cancer screening. 2013.
|
|
6.
|
Levine JS and Ahnen DJ: Adenomatous polyps
of the colon. N Engl J Med. 355:2551–2557. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Leggett B and Whitehall V: Role of the
serrated pathway in colorectal cancer pathogenesis.
Gastroenterology. 138:2088–2100. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Fujita K, Yamamoto H, Matsumoto T, et al:
Sessile serrated adenoma with early neoplastic progression: a
clinicopathologic and molecular study. Am J Surg Pathol.
35:295–304. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Winawer SJ, Zauber AG, Fletcher RH, et al:
Guidelines for colonoscopy surveillance after polypectomy: a
consensus update by the US Multi Society Task Force on colorectal
cancer and the American Cancer Society. Gastroenterology.
130:1872–1885. 2006. View Article : Google Scholar
|
|
10.
|
Martínez ME, Baron JA, Lieberman DA, et
al: A pooled analysis of advanced colorectal neoplasia diagnoses
after colonoscopic polypectomy. Gastroenterology. 136:832–841.
2009.PubMed/NCBI
|
|
11.
|
Rizzo A, Pallone F, Monteleone G, et al:
Intestinal inflammation and colorectal cancer: a double-edged
sword? World J Gastroenterol. 17:3092–3100. 2011.PubMed/NCBI
|
|
12.
|
Butterworth AS, Higgins JP and Pharoah P:
Relative and absolute risk of colorectal cancer for individuals
with a family history: a meta-analysis. Eur J Cancer. 42:216–227.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Jasperson KW, Tuohy TM, Neklason DW, et
al: Hereditary and familial colon cancer. Gastroenterology.
138:2044–2058. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Lynch HT and de la Chapelle A: Hereditary
colorectal cancer. N Engl J Med. 348:919–932. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Stoffel E, Mukherjee B, Raymond VM, et al:
Calculation of risk of colorectal and endometrial cancer among
patients with Lynch syndrome. Gastroenterology. 137:1621–1627.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Galiatsatos P and Foulkes WD: Familial
adenomatous polyposis. Am J Gastroenterol. 101:385–398. 2006.
View Article : Google Scholar
|
|
17.
|
Lubbe SJ, Di Bernardo MC, Chandler IP, et
al: Clinical implications of the colorectal cancer risk associated
with MUTYH mutation. J Clin Oncol. 27:3975–3980. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
McGarrity TJ and Amos C: Peutz-Jeghers
syndrome: clinicopathology and molecular alterations. Cell Mol Life
Sci. 63:2135–2144. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Brosens LA, van Hattem A, Hylind LM, et
al: Risk of colorectal cancer in juvenile polyposis. Gut.
56:965–967. 2007. View Article : Google Scholar
|
|
20.
|
Boparai KS, Mathus-Vliegen EM, Koornstra
JJ, et al: Increased colorectal cancer risk during follow-up in
patients with hyper-plastic polyposis syndrome: a multicentre
cohort study. Gut. 59:1098–1100. 2010.PubMed/NCBI
|
|
21.
|
Alexander DD, Weed DL, Cushing CA, et al:
Meta-analysis of prospective studies of red meat consumption and
colorectal cancer. Eur J Cancer Prev. 20:293–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Park JY, Mitrou PN, Dahm CC, et al:
Baseline alcohol consumption, type of alcoholic beverage and risk
of colorectal cancer in the European Prospective Investigation into
Cancer and Nutrition-Norfolk study. Cancer Epidemiol. 33:347–354.
2009. View Article : Google Scholar
|
|
23.
|
Kant P and Hull MA: Excess body weight and
obesity - the link with gastrointestinal and hepatobiliary cancer.
Nat Rev Gastroenterol Hepatol. 8:224–238. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Giouleme O, Diamantidis MD and Katsaros
MG: Is diabetes a causal agent for colorectal cancer?
Pathophysiological and molecular mechanisms. World J Gastroenterol.
17:444–448. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Jin P, Lu XJ, Sheng JQ, et al: Estrogen
stimulates the expression of mismatch repair gene hMLH1 in colonic
epithelial cells. Cancer Prev Res. 3:910–916. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Ullman TA and Itzkowitz SH: Intestinal
inflammation and cancer. Gastroenterology. 140:1807–1816. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Gallimore AM and Godkin A: Epithelial
barriers, microbiota, and colorectal cancer. N Engl J Med.
368:32013. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Markowitz SD and Bertagnolli MM: Molecular
basis of colorectal cancer. N Engl J Med. 361:2449–2460. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Pino MS and Chung DC: The chromosomal
instability pathway in colon cancer. Gastroenterology.
138:2059–2072. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Hewish M, Lord CJ, Martin SA, et al:
Mismatch repair deficient colorectal cancer in the era of
personalized treatment. Nat Rev Clin Oncol. 7:197–208. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Ligtenberg MJ, Kuiper RD, Chan TL, et al:
Heritable somatic methylation and inactivation of MSH2 in families
with Lynch syndrome due to deletion of the 3′ exons of TACSTD1. Nat
Genet. 41:112–117. 2009.PubMed/NCBI
|
|
32.
|
Pritchard CC and Grady WM: Colorectal
cancer molecular biology moves into clinical practice. Gut.
60:116–129. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Weisenberger DJ, Siegmund KD, Campan M, et
al: CpG island methylator phenotype underlies sporadic
microsatellite instability and is tightly associated with BRAF
mutation in colorectal cancer. Nat Genet. 38:787–793. 2006.
View Article : Google Scholar
|
|
34.
|
Hinoue T, Weisenberger DJ, Pan F, et al:
Analysis of the association between CIMP and BRAF in colorectal
cancer by DNA methylation profiling. PLoS One. 4:e83572009.
View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Powell S, Zilz N, Beazer-Barclay Y, et al:
APC mutations occur early during colorectal tumorigenesis. Nature.
359:235–237. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Cottrell S, Bicknell D, Kaklamanis L, et
al: Molecular analysis of APC mutations in familial adenomatous
polyposis and sporadic colon carcinomas. Lancet. 340:626–630. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Nieuwenhuis MH and Vasen HF: Correlations
between mutation site in APC and phenotype of familial adenomatous
polyposis (FAP): a review of the literature. Crit Rev Oncol
Hematol. 61:153–161. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Rennert G, Almog R, Tomsho LP, et al:
Colorectal polyps in carriers of the APC I1307K polymorphism. Dis
Colon Rectum. 48:2317–2321. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Kim YS and Deng G: Epigenetic changes
(aberrant DNA methylation) in colorectal neoplasia. Gut Liver.
1:1–11. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Goss KH and Groden J: Biology of the
adenomatous polyposis coli tumor suppressor. J Clin Oncol.
18:1967–1979. 2000.PubMed/NCBI
|
|
41.
|
Greenhough A, Smartt HJ, Moore AE, et al:
The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and
adaptation to the tumour microenvironment. Carcinogenesis.
30:377–386. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Vogelstein B, Fearon ER, Hamilton SR, et
al: Genetic alterations during colorectal-tumor development. N Engl
J Med. 319:525–532. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Todaro M, Francipane MG, Medema JP, et al:
Colon cancer stem cells: promise of targeted therapy.
Gastroenterology. 138:2151–2162. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Zeki SS, Graham TA and Wright NA: Stem
cells and their implications for colorectal cancer. Nat Rev
Gastroenterol Hepatol. 8:90–100. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Rabeneck L, Paszat LF, Saskin R, et al:
Association between colonoscopy rates and colorectal cancer
mortality. Am J Gastroenterol. 105:1627–1632. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Levin B, Lieberman DA, McFarland B, et al:
Screening and surveillance for the early detection of colorectal
cancer and adenomatous polyps, 2008: a joint guideline from the
American Cancer Society, the US Multi-Society Task Force on
Colorectal Cancer, and the American College of Radiology.
Gastroenterology. 134:1570–1595. 2008. View Article : Google Scholar
|
|
47.
|
Johnson CD, Chen MH, Toledano AY, et al:
Accuracy of CT colonography for detection of large adenomas and
cancers. N Engl J Med. 359:1207–1217. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Laghi A, Iafrate F, Rengo M, et al:
Colorectal cancer screening: The role of CT colonography. World J
Gastroenterol. 16:3987–3994. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Pickhardt PJ and Kim DH: Performance of CT
colonography for detecting small, diminutive, and flat polyps.
Gastrointest Endosc Clin N Am. 20:209–226. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Atkin WS, Edwards R, Kralj-Hans I, et al:
Once-only flexible sigmoidoscopy screening in prevention of
colorectal cancer: a multicentre randomised controlled trial.
Lancet. 375:1624–1633. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Hewitson P, Glasziou P, Watson E, et al:
Cochrane systematic review of colorectal cancer screening using the
fecal occult blood test (hemoccult): an update. Am J Gastroenterol.
103:1541–1549. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52.
|
Vasen HF, Watson P, Mecklin JP, et al: New
clinical criteria for hereditary nonpolyposis colorectal cancer
(HNPCC, Lynch syndrome) proposed by the International Collaborative
group on HNPCC. Gastroenterology. 116:1453–1456. 1999. View Article : Google Scholar
|
|
53.
|
Umar A, Boland CR, Terdiman JP, et al:
Revised Bethesda guidelines for hereditary nonpolyposis colorectal
cancer (Lynch syndrome) and microsatellite instability. J Natl
Cancer Inst. 96:261–268. 2004. View Article : Google Scholar
|
|
54.
|
Berg AO, Armstrong K, Botkin J, et al:
Recommendations from the EGAPP Working Group: genetic testing
strategies in newly diagnosed individuals with colorectal cancer
aimed at reducing morbidity and mortality from Lynch syndrome in
relatives. Evaluation of Genomic Applications in Practice and
Prevention (EGAPP) Working Group. Genet Med. 11:35–41. 2009.
|
|
55.
|
Beggs AD, Latchford AR, Vasen HF, et al:
Peutz-Jeghers syndrome: a systematic review and recommendations for
management. Gut. 59:975–986. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56.
|
Brosens LA, Langeveld D and van Hattem WA:
Juvenile polyposis syndrome. World J Gastroenterol. 17:4839–4844.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
57.
|
Imperiale TF, Ransohoff DF, Itzkowitz SH,
et al: Fecal DNA versus fecal occult blood for colorectal-cancer
screening in an average-risk population. N Engl J Med.
351:2704–2714. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
58.
|
Ahlquist DA: Next-generation stool DNA
testing: expanding the scope. Gastroenterology. 136:2068–2073.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
59.
|
Ahlquist DA, Sargent DJ, Loprinzi CL, et
al: Stool DNA and occult blood testing for screen detection of
colorectal neoplasia. Ann Intern Med. 149:441–450. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
60.
|
Van Gossum A, Munoz-Navas M,
Fernandez-Urien I, et al: Capsule endoscopy versus colonoscopy for
the detection of polyps and cancer. N Engl J Med. 361:264–270.
2009.
|
|
61.
|
Brenner H MD, Chang-Claude J, Seiler CM,
et al: Protection from colorectal cancer after colonoscopy. A
population-based, case-control study. Ann Intern Med. 154:22–30.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
62.
|
Ferrara F, Luigiano C, Ghersi S, et al:
Efficacy, safety and outcomes of ‘inject and cut’ endoscopic
mucosal resection for large sessile and flat colorectal polyps.
Digestion. 82:213–220. 2010.
|
|
63.
|
Kirkegaard H, Johnsen NF, Christensen J,
et al: Association of adherence to lifestyle recommendations and
risk of colorectal cancer: a prospective Danish cohort study. BMJ.
341:c55042010. View Article : Google Scholar : PubMed/NCBI
|
|
64.
|
Manson JE, Mayne ST and Clinton SK:
Vitamin D and prevention of cancer-ready for prime time? N Engl J
Med. 364:1385–1387. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
65.
|
Park Y, Spiegelman D, Hunter DJ, et al:
Intakes of vitamins A, C, and E and use of multiple vitamin
supplements and risk of colon cancer: a pooled analysis of
prospective cohort studies. Cancer Causes Control. 21:1745–1757.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
66.
|
Kennedy DA, Stern SJ, Moretti M, et al:
Folate intake and the risk of colorectal cancer: a systematic
review and meta-analysis. Cancer Epidemiol. 35:2–10. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
67.
|
Chan AT: Aspirin and familial adenomatous
polyposis: coming full circle. Cancer Prev Res (Phila). 4:623–627.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
68.
|
Cole BF, Logan RF, Halabi S, et al:
Aspirin for chemoprevention of colorectal adenomas: meta-analysis
of the randomised trials. J Natl Cancer Inst. 101:256–266. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
69.
|
Tsujii M: Search for novel target
molecules for the effective treatment or prevention of colorectal
cancer. Digestion. 85:99–102. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
70.
|
Rothwell PM, Wilson M, Elwin CE, et al:
Long-term effect of aspirin on colorectal cancer incidence and
mortality: 20-year follow-up of five randomised trials. Lancet.
376:1741–1750. 2010.PubMed/NCBI
|
|
71.
|
Long MD, Martin CF, Galanko JA, et al:
Hormone replacement therapy, oral contraceptive use and distal
large bowel cancer: a population-based case-control study. Am J
Gastroenterol. 105:1843–1850. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
72.
|
Baron JA: Statins and the colorectum: hope
for chemoprevention? Cancer Prev Res. 3:573–575. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
73.
|
Chan AT and Giovannucci EL: Primary
prevention of colorectal cancer. Gastroenterology. 138:2029–2043.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
74.
|
Chu E: An update on the current and
emerging targeted agents in metastatic colorectal cancer. Clin
Colorectal Cancer. 11:1–13. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
75.
|
Parry S, Win AK, Parry B, et al:
Metachronous colorectal cancer risk for mismatch repair gene
mutation carriers: the advantage of more extensive colon surgery.
Gut. 60:950–957. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
76.
|
Obermair A, Youlden DR, Young JP, et al:
Risk of endometrial cancer for women diagnosed with HNPCC-related
colorectal carcinoma. Int J Cancer. 127:2678–2684. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
77.
|
Arber N, Spicak J, Rácz I, et al:
Five-year analysis of the prevention of colorectal sporadic
adenomatous polyps trial. Am J Gastroenterol. 106:1135–1346.
2011.PubMed/NCBI
|
|
78.
|
Bolocan A, Ion D, Stoian RV, et al: MAP
syndrome (MYH associated polyposis) colorectal cancer,
etiopathological connections. J Med Life. 4:109–111.
2011.PubMed/NCBI
|
